Valius Health, Inc.

Biotech San Francisco, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
San Francisco, CA
Street
8 California Street
Zip
94111

Offering

Total offering
$10.2M
Amount sold
$9.7M
First sale
Mar 25, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
6

How this filing compares

Ranked #10 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 3.4× the median.

Other California filings this week: Blue Opportunity Fund, LP, CHECKPOINT CAPITAL (OFFSHORE) FUND LP, CHECKPOINT CAPITAL (ONSHORE) FUND LP, CompleteFarmer Technologies, Inc., ExchangeRight Income Fund Operating Partnership, LP

Leadership

Edward Larkin — Executive Officer (also: Director)

Filing details

Valius Health, Inc. filed a Form D with the SEC on April 13, 2026.

Other newest Biotech companies

Other newest companies in California